MYOD1 and hepatocellular carcinoma: MiR‐501‐3p also directly targets the Lin‐7 homolog A (LIN7A) gene to repress the development of hepatocellular carcinoma,16 and its direct regulation of the Fos proto‐oncogene (FOS), myogenic differentiation (MyoD) gene, and MyoD family inhibitor (MDFI) gene may be involved in the pathogenesis of skeletal muscle metabolic diseases.17